Howard Curtis
About Howard Curtis
Howard Curtis is a Senior Account Manager in Transplant and Immunoscience at Bristol-Myers Squibb in Denver, CO, with 29 years of experience in the pharmaceutical and biotech sectors.
Current Role at Bristol-Myers Squibb
Howard Curtis serves as the Senior Account Manager in Transplant and Immunoscience at Bristol-Myers Squibb in Denver, CO. His role entails specializing in immunoscience, with a particular focus on immunosuppressive therapy (Belatacept) and rheumatoid arthritis treatment (Orencia) within the Midwest region.
Previous Positions at Bristol-Myers Squibb
Before his current position, Howard Curtis worked as a Senior Institutional Sales Manager in the Cardiovascular division from 2016 to 2019 in Maine. He also served as a Senior Transplant Account Manager through Quintiles at Bristol-Myers Squibb from 2015 to 2016, covering Upstate New York and Pennsylvania (excluding Philadelphia).
Extensive Career in Pharmaceutical Sector
Howard Curtis has a robust career trajectory with 29 years of experience in the pharmaceutical and biotech sectors. His career includes roles in various specialties such as pain, neurology, primary care, geriatrics, orthopedics, general surgery, pulmonology, allergy, pediatrics, neurosurgery, nephrology, kidney transplant, infectious disease, and hematology/oncology. This diverse expertise spans management of geographic territories like New England, the Albany NY capital region, Pennsylvania, and the Midwest.
Education Background
Howard Curtis attended the United States Military Academy at West Point, where he studied Mechanical Engineering and obtained a Bachelor's degree. He completed his education there from 1982 to 1986.
Experience in Diverse Geographic Territories
Throughout his career, Howard Curtis has managed several diverse geographic territories including New England, the Albany NY capital region, Pennsylvania, and the Midwest. His experience includes calling on office-based clinicians and hospitals ranging from large academic institutions to smaller community hospitals.